Key result
ABCG5/ABCG8 loss-of-function variants cause sitosterolemia, premature atherosclerosis, and hematologic defects responsive to ezetimibe.
Answers are grounded in this paper and cite their sources.
This review details the ABCG5/ABCG8 mutation spectrum and pathogenic mechanisms in sitosterolemia, emphasizing the importance of plasma phytosterol measurement and genetic testing to prevent misdiagnosis as familial hypercholesterolemia or hematologic disorders and to guide targeted ezetimibe therapy.
Sitosterolemia represents a rare autosomal recessive disorder of lipid metabolism, defined by the pathological accumulation of phytosterols—notably sitosterol and campesterol—in both plasma and tissues. This biochemical aberration precipitates severe clinical sequelae, including premature atherosclerosis, hemolytic anemia, and arthritis. The etiology is firmly established as loss-of-function mutations in ABCG5 and ABCG8 , which encode critical sterol efflux transporters. This review systematically dissects the molecular genetic architecture of sitosterolemia, offering a comprehensive evaluation of the ABCG5/ABCG8 mutation spectrum. Our analysis encompasses canonical homozygous and compound heterozygous variants, while also addressing the emerging significance of monoallelic heterozygous mutations. We further examine how specific genotypic alterations impair transporter function and correlate with phenotypic severity. Moreover, by synthesizing recent findings, we investigate whether heterozygous carriers manifest subclinical traits characterized by incomplete penetrance and assess their associated pathogenic risks. Ultimately, this work establishes a robust theoretical framework to advance precise diagnosis, refine genetic counseling strategies, and facilitate personalized clinical management of sitosterolemia.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) conducted a review in Sitosterolemia. ABCG5 and ABCG8 loss-of-function mutations was evaluated. Loss-of-function variants in ABCG5 and ABCG8 impair sterol efflux, causing systemic phytosterol accumulation, premature atherosclerosis, and hematologic abnormalities responsive to ezetimibe.
Synapse has enriched 10 related papers. Consider them for comparative context: